✦ LIBER ✦

Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure

✍ Scribed by D.M McNamara; R Holubkov; K Janosko

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacogenetic interactions between ang

✍ D.M. McNamara; R. Holubkov; L. Postava 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Angiotensin-converting enzyme inhibitors

✍ Alan K. Berger; Sue Duval; Connie Manske; Gabriela Vazquez; Cheryl Barber; Lesli 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 294 KB

The impact of beta-receptor blocker addi

✍ T. Barry Levine; Arlene B. Levine; Steven J. Keteyian; Barbara Narins 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 572 KB

Treatment with angiotensin converting en

✍ Ragnar Watz; Ann-Britt Ekstrand; Victoria Engelbrektson; Björn Beermann 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 284 KB

Effects of the replacement of the angiot

✍ P.H.J.M Dunselman 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Effect of beta blockers alone, of angiot

✍ Wilbert S Aronow; Chul Ahn; Itzhak Kronzon 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 56 KB